Recent News

Allocetra and Cisplatin Combination for Mesothelioma

September 16, 2022

A new immunotherapy treatment is showing promising results against mesothelioma. The therapy consists of a combination of two drugs: one drug that reprograms macrophages and the other is the chemotherapy…

Tool to Measure Asbestos Levels in Tissue has Been Created

September 9, 2022

A new tool to determine levels of asbestos exposure has been developed. The tool, created by Italian researchers, is known as a Retrospective Exposure Assessment (REA). The tool uses a…

AMT-151 in Patients With Selected Advanced Solid Tumours

September 2, 2022

Primary Outcome Measures Recommended Phase 2 Dose (RP2D) [ Time Frame: Up to 24 months ] The RP2D will be determined using dose limiting toxicities (DLTs) and all other available study data Maximum Tolerated…

Drug Factories Treatment Being Tested for Mesothelioma

September 2, 2022

Researchers have found a treatment that can eradicate advanced stage mesothelioma tumors within a few days. The research is being done at Rice University and Baylor College of Medicine. The…

Oral AMXT 1501 Dicaprate in Combination With IV DFMO

August 26, 2022

Primary Outcome Measures Determine DLTs and RP2Ds in AMXT 1501 in combination with IV DFMO [ Time Frame: 1 year ] Indicate Number of patients with DLTs in AMXT1501 in combination with IV DFMO…

Keytruda as a Second Line Treatment for Mesothelioma

August 26, 2022

A new second line treatment has been developed for pleural mesothelioma. The treatment was created at the Netherlands Cancer Institute in Amsterdam. Research was done as a single-arm, open-label clinical…

Effect of HITHOC After Pleurectomy Decortication for Treatment of Malignant Pleural Mesothelioma

August 19, 2022

Primary Outcome Measures disease free survival or time to recurrence [ Time Frame: Through out the whole study with maximum of 2 years ] time from clearance of disease till onset of recurrence of…

A New Blood Test That Can Diagnose Mesothelioma Has Been Developed

August 19, 2022

A blood test could make diagnosing mesothelioma faster, leading to doctors catching the disease earlier in patients. Mesothelioma is a hard-to-treat cancer mainly caused by asbestos. Once diagnosed, not much…

Researchers Found a Relationship Between GISTs and Peritoneal Mesothelioma

August 12, 2022

Scientists may have found an easy way to identify peritoneal mesothelioma, making it easier to detect and catch the cancer earlier. These researchers may have found a link between peritoneal…

Researchers Possibly Found a MicroRNA Biomarker to Diagnose Mesothelioma

August 5, 2022

Italian researchers have potentially found a new biomarker for mesothelioma. The biomarker is a microRNA signature. This would allow doctors to determine if someone’s cancer is mesothelioma or another type…